BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//N2 Canada - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:N2 Canada
X-ORIGINAL-URL:https://n2canada.ca
X-WR-CALDESC:Events for N2 Canada
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240717T110000
DTEND;TZID=America/Toronto:20240717T120000
DTSTAMP:20260317T043924
CREATED:20240603T155843Z
LAST-MODIFIED:20240603T155843Z
UID:12444-1721214000-1721217600@n2canada.ca
SUMMARY:Webinar - Racial and Ethnic Diversity in Pediatric Clinical Trials: Current Barriers and a Path Towards Inclusive Clinical Trial Design and Conduct
DESCRIPTION:Webinar objectives: \n\n\nUnderstand the role that historical and ongoing marginalization play in research participation \n\n\nDiscuss how research findings in homogeneous populations are not generalizable to all children \n\n\nDescribe research approaches that can improve diversity and inclusion in pediatric clinical trials \n\n\nMeet the speaker!\nDr Tamorah Lewis is a physician scientist\, Division Head for Clinical Pharmacology and Toxicology at SickKids. In this role\, Dr Lewis helps advance the hospital-wide vision for Precision Child Health and collaborates with multiple clinical Divisions for pharmacology research. Dr Lewis also continues to provide clinical care in the level IV Neonatal ICU at SickKids. The goals of Dr Lewis’ research program are to bring precision therapeutics to the NICU population. Dr Lewis’ interests include PBPK and population pharmacokinetic and pharmacodynamic investigations in neonates and children\, pertaining to both drugs in common use and drugs under development. Her research focuses on the intersection between ontogeny and pharmacogenetic effects on pharmacology of drugs in infants and neonates. In addition to her clinical and research roles\, Dr Lewis is a dedicated advocate for Health Equity. Through publications and talks\, she educates about the need for increased diversity in the biomedical workforce and the importance of diversity and equity in clinical research and clinical care.
URL:https://n2canada.ca/event/webinar-racial-and-ethnic-diversity-in-pediatric-clinical-trials-current-barriers-and-a-path-towards-inclusive-clinical-trial-design-and-conduct/
LOCATION:Zoom
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/06/Central-Regional-Meeting-Presentation-4.png
END:VEVENT
END:VCALENDAR